These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9793877)

  • 1. The limitations of antipsychotic medication on schizophrenia relapse and adjustment and the contributions of psychosocial treatment.
    Hogarty GE; Ulrich RF
    J Psychiatr Res; 1998; 32(3-4):243-50. PubMed ID: 9793877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients.
    Hogarty GE; Greenwald D; Ulrich RF; Kornblith SJ; DiBarry AL; Cooley S; Carter M; Flesher S
    Am J Psychiatry; 1997 Nov; 154(11):1514-24. PubMed ID: 9356558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive psychosocial therapies for the treatment of schizophrenia.
    Patterson TL; Leeuwenkamp OR
    Schizophr Res; 2008 Mar; 100(1-3):108-19. PubMed ID: 18226500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of relapse in schizophrenia.
    Weiden PJ; Olfson M
    Schizophr Bull; 1995; 21(3):419-29. PubMed ID: 7481573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.
    De Hert M; Sermon J; Geerts P; Vansteelandt K; Peuskens J; Detraux J
    CNS Drugs; 2015 Aug; 29(8):637-58. PubMed ID: 26293744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
    Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
    Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.
    Hogarty GE
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):36-42. PubMed ID: 6143746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Psychosocial' interventions with families and their effects on the course of schizophrenia: a review.
    Barrowclough C; Tarrier N
    Psychol Med; 1984 Aug; 14(3):629-42. PubMed ID: 6149587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of schizophrenia.
    Kane JM
    Schizophr Bull; 1987; 13(1):133-56. PubMed ID: 2885912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. II. Two-year effects of a controlled study on relapse and adjustment. Environmental-Personal Indicators in the Course of Schizophrenia (EPICS) Research Group.
    Hogarty GE; Anderson CM; Reiss DJ; Kornblith SJ; Greenwald DP; Ulrich RF; Carter M
    Arch Gen Psychiatry; 1991 Apr; 48(4):340-7. PubMed ID: 1672589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance therapy of persons with schizophrenia.
    Carpenter WT
    J Clin Psychiatry; 1996; 57 Suppl 9():10-8. PubMed ID: 8823345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection.
    Lee SH; Choi TK; Suh S; Kim YW; Kim B; Lee E; Yook KH
    Psychiatry Res; 2010 Feb; 175(3):195-9. PubMed ID: 20022120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia.
    Schooler NR
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):11S-19S. PubMed ID: 2870086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies.
    Gaebel W; Jänner M; Frommann N; Pietzcker A; Köpcke W; Linden M; Müller P; Müller-Spahn F; Tegeler J
    Schizophr Res; 2002 Jan; 53(1-2):145-59. PubMed ID: 11728846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. I. One-year effects of a controlled study on relapse and expressed emotion.
    Hogarty GE; Anderson CM; Reiss DJ; Kornblith SJ; Greenwald DP; Javna CD; Madonia MJ
    Arch Gen Psychiatry; 1986 Jul; 43(7):633-42. PubMed ID: 2872870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating pharmacological and psychosocial treatments for schizophrenia.
    Marder SR
    Acta Psychiatr Scand Suppl; 2000; (407):87-90. PubMed ID: 11261649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptics and psychosocial treatments: a discussion.
    Schooler NR
    Schizophr Bull; 1980; 6(1):131-4. PubMed ID: 6102790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A program for relapse prevention in schizophrenia: a controlled study.
    Herz MI; Lamberti JS; Mintz J; Scott R; O'Dell SP; McCartan L; Nix G
    Arch Gen Psychiatry; 2000 Mar; 57(3):277-83. PubMed ID: 10711914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.